Meclizine HCl MECLIZINE HYDROCHLORIDE CHEWABLE 25 mg Tablet, Chewable, 1,000-count
by BluePoint Laboratories · 1000 TABLET, CHEWABLE in 1 BOTTLE (68001-529-08)
NDC 68001-0529-08
🏷️ FDA NDC (as labeled)
68001-529-08
billing pads the product segment with a zero
This package
Also priced by: Medicaid pays $0.2637/unit — full pricing hub ↓
Also comes in:
100 tablets 68001-0529-00
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
68001-529-08
Product NDC
68001-529
11-digit billing NDC
68001052908
NCPDP billing unit
EA — each (per item)
RxCUI
995632
UNII
HDP7W44CIO
UPC
0368001529082
Application #
M009
SPL Set ID
d9cc2705-9dcc-0a73-e053-2995a90aafe6
Established class (EPC)
Antiemetic
Physiologic effect
Emesis Suppression
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2022-03-14
Route
ORAL
Dosage form
TABLET, CHEWABLE
Substance
MECLIZINE HYDROCHLORIDE
GPI-14
50200050000510
GPI class
Meclizine HCl
GCN Seq No
004736
GCN
18312
HICL code
001975
Ingredient (HICL)
Meclizine Hcl
HIC1 code
H
Therapeutic class — broad (HIC1)
Nervous System (Except Autonomic)
HIC2 code
H6
Therapeutic class — intermediate (HIC2)
Drugs Acting Principally On The Midbrain
HIC3 code
H6J
Therapeutic class — specific (HIC3)
Antiemetic/Antivertigo Agents
AHFS code
04:04.16.00
AHFS class
Piperazine Derivatives
FDB label name
MECLIZINE 25 MG TABLET CHEW
FDB brand name
Meclizine Hcl
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 68001-529-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68001-0529-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Antiemetic class.
Pharmacologic class
Antiemetic
Drug family (ATC)
Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerBluePoint Laboratories
FDA applicationM009 (OTC MONOGRAPH DRUG)
Labeler code68001
First marketedMar 2022
Product typeHuman Otc Drug
Portfolio347 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name MECLIZINE 25 MG TABLET CHEW Ingredient Meclizine Hcl
📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about MECLIZINE HYDROCHLORIDE CHEWABLE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII Z0H242BBR1
Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII IY9XDZ35W2
Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 7CVR7L4A2D
A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 4N14V5R27W
A natural flavoring derived from raspberry fruit that gives medicines a pleasant taste. It helps mask bitter or unpleasant flavors to make medications easier to swallow.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 36KCS0R750
Sodium sulfate anhydrous is a salt derived from sodium and sulfuric acid. It acts as a filler and diluent in tablets and capsules to add bulk and help achieve proper tablet size and weight.
-
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
-
UNII 91D9GV0Z28
A mineral salt made from calcium and phosphate. It acts as a filler to add bulk to the tablet or capsule, and helps bind ingredients together so the medicine holds its shape.
12 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesaspartame, colloidal silicon dioxide, croscarmellose sodium, dextrose, lake of FD & C Red 40, magnesium stearate, maltodextrin, microcrystalline cellulose, raspberry flavor, sodium sulfate anhydrous, sucrose, tribasic calcium phosphate
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.033 | $33.30 / 1000 tablets |
| Medicaid paysCMS SDUD · 12 mo | $0.2637 | $263.70 / 1000 tablets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
Flat over the last 14 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride 25 mg 00536-1299-01 | Rugby | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mg 16571-0824-01 | Rising | 100 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 46122-0774-51 | Amerisource | 8 tablets | $0.033 | — | Availability likely | — |
| Motion-Time Chewable 25 mg/251 49483-0333-01 | Time-Cap | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mgthis 68001-0529-08 | BluePoint | 1000 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness 25 mg 70677-1290-01 | Strategic | 100 tablets | $0.033 | — | Availability likely | — |
| Travel ease 25 mg 83324-0027-16 | Chain | 8 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 00363-4040-21 | Walgreen | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 00363-5172-07 | Walgreen | 12 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 11822-4040-01 | Rite | 8 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 16103-0387-08 | Pharbest | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 16571-0663-01 | Rising | 100 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 17714-0115-01 | Advance | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 37835-0202-01 | Bi-Mart | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 43063-0804-01 | PD-Rx | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5496-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5952-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51013-0322-54 | PuraCap | 2 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51316-0404-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Motion Sickness 25 mg 51316-0441-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 54738-0025-01 | Richmond | 100 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0906-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0913-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0914-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0275-02 | WellSpring | 2 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0296-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0297-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-2574-02 | NuCare | 20 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 68788-7982-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 68788-8529-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 69618-0028-01 | Reliable | 100 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 69842-0395-54 | CVS | 2 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71205-0606-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 71335-1215-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71335-1607-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71335-2177-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 71335-9751-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71610-0528-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71610-0836-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 72789-0250-12 | PD-Rx | 12 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 80513-0421-02 | Advanced | 200 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2022
On the market since
Mar 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 68001-0529-08, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7.1K
Units reimbursed last 4 qtrs
330.5K
Gross reimbursed last 4 qtrs
$87.2K
Avg / prescription
$12.22
Avg / unit
$0.2637
Latest quarter Q4 2025
2KRx
Medicaid pays / ea
$0.2637
gross reimbursed
vs
NADAC / ea
$0.0333
acquisition cost
=
Spread
+$0.2304
+692% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 6,601 Rx Managed care · 528 Rx
State Medicaid map
Units reimbursed · per 100k residents
6.5726
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 9,542 Rx · 450,296 units · $114,775 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Meclizine HCl — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Meclizine HCl. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.73M
Claims incl. refills
748.9K
Beneficiaries
532.6K
Spend / beneficiary
$12.64
Spend / claim
$8.99
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Meclizine HCL (this brand).
Top reported reactions
Reporter sex
Male · 25%
Female · 75%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 68001-0529-00 | 100 TABLET, CHEWABLE in 1 BOTTLE (68001-529-00) | $0.0333 / ea | $3.33 | 2022-03-14 | Active |
| 68001-0529-08 You're viewing this | 1000 TABLET, CHEWABLE in 1 BOTTLE (68001-529-08) | $0.0333 / ea | $33.31 | 2022-03-14 | Active |
You're viewing the largest of 2 pack sizes for this product.
This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0333 NADAC).
In Medicaid, this is the most-dispensed pack of this product — about 75% of fills over the last four reported quarters. See all packs ↓
Pack size FAQ
What quantity is in NDC 68001-0529-08?
NDC 68001-0529-08 is a 1,000-count package — 1000 tablet, chewable in 1 bottle.
What is the difference between NDC 68001-0529-08 and NDC 68001-0529-00?
Both are Meclizine HCl MECLIZINE HYDROCHLORIDE CHEWABLE 25 mg Tablet, Chewable — the drug itself is identical. NDC 68001-0529-08 is the 1,000-count package, while NDC 68001-0529-00 is the 100 tablets package.
What NDC number is used to bill for this package of Meclizine HCl MECLIZINE HYDROCHLORIDE CHEWABLE 25 mg Tablet, Chewable?
Bill NDC 68001-0529-08 — the 11-digit billing format is 68001052908. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses prevents and treats nausea, vomiting or dizziness due to motion sickness.
⏱️ Dosage and Administration ▾
Directions Dosage should be taken one hour before travel starts Adults and children 12 years and older: Chew 1-2 tablets once daily, or as directed by a doctor Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor
⚠️ Warnings ▾
Warnings Do not use in children under 12 years of age unless directed by a doctor Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an enlarged prostate gland
📦 Storage and Handling ▾
Other Information Phenylketonurics: Contains Phenylalanine 0.0025 mg per tablet Store at room temperature in a dry place Keep lid tightly closed
🧪 Active Ingredient ▾
Drug Facts Active ingredient (in each chewable tablet) Meclizine HCl, USP 25 mg
🧪 Inactive Ingredients ▾
Inactive ingredients aspartame, colloidal silicon dioxide, croscarmellose sodium, dextrose, lake of FD & C Red 40, magnesium stearate, maltodextrin, microcrystalline cellulose, raspberry flavor, sodium sulfate anhydrous, sucrose, tribasic calcium phosphate
🎯 Purpose ▾
Purpose Antiemetic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.